Great post here and I firmly believe this class of drugs will change the current landscape of metabolic disease and obesity.
We as a society are ridden with inflammation due to environmental factors, processed foods, and the lack of overall willingness to change our ways.
Most people could not go 24 hours without eating. Most are all addicted to food and have constant food noise bombarding us 24/7.
And sadly most do not have the willpower to change, but with a GLP the friction is removed. You can call it cheating or the lazy way out, but it works and it works well.
Just a few ways GLPs are fighting this epidemic
- lower inflammation
- better glucose handling and insulin sensitivity
- reduced appetite and quieter food noise
- sustained weight loss
- improved blood pressure and cholesterol markers
I was the biggest critic of peptides, especially the GLP class, until I actually tried them and saw my blood levels along with how I felt improve drastically.
GLPs: The Cure for the ails of the modern age:
The more we learn about the GLP class, the more exciting it gets; these truly are the modern day penicillin.
Penicillin was discovered and has saved 500+ million lives that would have been lost to bacterial infections otherwise.
GLPs are doing something similar for an entirely different set of afflictions: the obesity epidemic, relentless overconsumption of super engineered food stuffs, and the compulsive draws of gambling and alcohol that have traditionally been written off as willpower failures. The GLP class is quickly and efficiently hunting down the diseases ravaging the modern era.
The Longer You Stay on GLP-1, the Better Your Body May Handle Blood Sugar Spikes
A study out of the Salk Institute published in March 2026 adds another layer to the history of GLP-1 research, which stretches back more than forty years. Outside of X, people have the idea that the GLP class compounds are “new” and “untested” and that couldn’t be further from reality.
Salk researchers found that prolonged GLP-1 exposure triggers a chemical modification, phosphorylation, on a protein called Med14, part of a larger complex that regulates gene expression throughout the genome.
Once that modification flips like a molecular switch, hundreds of genes turn on at once inside pancreatic beta cells, the cells that produce insulin, essentially reprogramming them to handle repeated glucose spikes with more resilience.
This is gene expression rather than genetic mutation which means nothing about the DNA sequence itself is changed.
What changes is which genes get turned on and how strongly they are expressed.
The caveats do matter here, since this is mouse and cultured beta cell data, not human confirmation, and the researchers used a generic GLP-1 receptor agonist rather than any specific branded compound. So no, this is not proof that Sema/Tirz/Reta specifically do this in a living person.
However, this is a more than intriguing mechanistic find for anyone running GLP class compounds long term and paying attention to their insulin sensitivity and partitioning, though it is far from settled science as of today.